146 related articles for article (PubMed ID: 26776251)
1. The Efficacy and Safety of Megestrol Acetate in Protein-Energy Wasting due to Chronic Kidney Disease: A Systematic Review.
Wazny LD; Nadurak S; Orsulak C; Giles-Smith L; Tangri N
J Ren Nutr; 2016 May; 26(3):168-76. PubMed ID: 26776251
[TBL] [Abstract][Full Text] [Related]
2. Using megestrol acetate to ameliorate protein-energy wasting in chronic kidney disease.
Smith CS; Logomarsino JV
J Ren Care; 2016 Mar; 42(1):53-9. PubMed ID: 26537025
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
4. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS; Lovitt S; Schuster MW
J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
[TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.
Rammohan M; Kalantar-Zadeh K; Liang A; Ghossein C
J Ren Nutr; 2005 Jul; 15(3):345-55. PubMed ID: 16007564
[TBL] [Abstract][Full Text] [Related]
6. The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients.
Zheng Z; Chen J; He D; Xu Y; Chen L; Zhang T
Int Urol Nephrol; 2019 Sep; 51(9):1631-1638. PubMed ID: 31359357
[TBL] [Abstract][Full Text] [Related]
7. The effects of megestrol acetate on nutritional parameters in a dialysis population.
Boccanfuso JA; Hutton M; McAllister B
J Ren Nutr; 2000 Jan; 10(1):36-43. PubMed ID: 10671632
[TBL] [Abstract][Full Text] [Related]
8. Optimizing end points and outcomes in cancer-associated wasting.
Dahele M; Wall L
J Clin Oncol; 2005 Apr; 23(12):2871-2; author reply 2872-3. PubMed ID: 15838010
[No Abstract] [Full Text] [Related]
9. Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients.
Gołębiewska JE; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Majkowicz M; Lysiak-Szydłowska W; Rutkowski B
Int Urol Nephrol; 2012 Aug; 44(4):1211-22. PubMed ID: 21805328
[TBL] [Abstract][Full Text] [Related]
10. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.
Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ
Ann Oncol; 1997 Mar; 8(3):277-83. PubMed ID: 9137798
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss.
Deutsch J; Kolhouse JF
Support Care Cancer; 2004 Jul; 12(7):503-10. PubMed ID: 15064933
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of uraemic anorexia with megestrol acetate].
Fernández Lucas M; Teruel JL; Burguera V; Sosa H; Rivera M; Rodríguez Palomares JR; Marcén R; Quereda C
Nefrologia; 2010; 30(6):646-52. PubMed ID: 21113214
[TBL] [Abstract][Full Text] [Related]
13. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
15. The effects of moderate doses of megestrol acetate on nutritional status and body composition in a hemodialysis patient.
Burrowes JD; Bluestone PA; Wang J; Pierson RN
J Ren Nutr; 1999 Apr; 9(2):89-94. PubMed ID: 10089265
[TBL] [Abstract][Full Text] [Related]
16. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate.
Chidakel AR; Zweig SB; Schlosser JR; Homel P; Schappert JW; Fleckman AM
J Endocrinol Invest; 2006 Feb; 29(2):136-40. PubMed ID: 16610239
[TBL] [Abstract][Full Text] [Related]
18. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
[TBL] [Abstract][Full Text] [Related]
19. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.
Costero O; Bajo MA; del Peso G; Gil F; Aguilera A; Ros S; Hevia C; Selgas R
Adv Perit Dial; 2004; 20():209-12. PubMed ID: 15384828
[TBL] [Abstract][Full Text] [Related]
20. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
